Literature DB >> 32651241

Obesity Is Associated With Increased Basal and Postprandial β-Cell Insulin Secretion Even in the Absence of Insulin Resistance.

Stephan van Vliet1,2, Han-Chow E Koh1, Bruce W Patterson1, Mihoko Yoshino1, Richard LaForest3, Robert J Gropler3, Samuel Klein1, Bettina Mittendorfer4.   

Abstract

We tested the hypothesis that obesity, independent of insulin resistance, is associated with increased insulin secretion. We compared insulin kinetics before and after glucose ingestion in lean healthy people and people with obesity who were matched on multiorgan insulin sensitivity (inhibition of adipose tissue lipolysis and glucose production and stimulation of muscle glucose uptake) as assessed by using a two-stage hyperinsulinemic-euglycemic pancreatic clamp procedure in conjunction with glucose and palmitate tracer infusions and positron emission tomography. We also evaluated the effect of diet-induced weight loss on insulin secretion in people with obesity who did not improve insulin sensitivity despite marked (∼20%) weight loss. Basal and postprandial insulin secretion rates were >50% greater in people with obesity than lean people even though insulin sensitivity was not different between groups. Weight loss in people with obesity decreased insulin secretion by 35% even though insulin sensitivity did not change. These results demonstrate that increased insulin secretion in people with obesity is associated with excess adiposity itself and is not simply a compensatory response to insulin resistance. These findings have important implications regarding the pathogenesis of diabetes because hyperinsulinemia causes insulin resistance and insulin hypersecretion is an independent risk factor for developing diabetes.
© 2020 by the American Diabetes Association.

Entities:  

Year:  2020        PMID: 32651241      PMCID: PMC7506835          DOI: 10.2337/db20-0377

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  30 in total

Review 1.  Lipid-associated metabolic signalling networks in pancreatic beta cell function.

Authors:  Marc Prentki; Barbara E Corkey; S R Murthy Madiraju
Journal:  Diabetologia       Date:  2019-08-19       Impact factor: 10.122

2.  Identification, pathophysiology, and clinical implications of primary insulin hypersecretion in nondiabetic adults and adolescents.

Authors:  Domenico Tricò; Andrea Natali; Silva Arslanian; Andrea Mari; Ele Ferrannini
Journal:  JCI Insight       Date:  2018-12-20

Review 3.  Mechanisms of Insulin Action and Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

4.  Determination of the lumped constant for [18F] fluorodeoxyglucose in human skeletal muscle.

Authors:  D E Kelley; K V Williams; J C Price; B Goodpaster
Journal:  J Nucl Med       Date:  1999-11       Impact factor: 10.057

5.  Glucose-stimulated insulin biosynthesis depends on insulin-stimulated insulin gene transcription.

Authors:  B Leibiger; K Wahlander; P O Berggren; I B Leibiger
Journal:  J Biol Chem       Date:  2000-09-29       Impact factor: 5.157

6.  Dynamics of insulin hypersecretion by obese Zucker rats.

Authors:  D L Curry; J S Stern
Journal:  Metabolism       Date:  1985-09       Impact factor: 8.694

7.  beta-Cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis.

Authors:  Ele Ferrannini; Amalia Gastaldelli; Yoshinori Miyazaki; Masafumi Matsuda; Andrea Mari; Ralph A DeFronzo
Journal:  J Clin Endocrinol Metab       Date:  2004-10-13       Impact factor: 5.958

Review 8.  Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage.

Authors:  Ranganath Muniyappa; Sihoon Lee; Hui Chen; Michael J Quon
Journal:  Am J Physiol Endocrinol Metab       Date:  2007-10-23       Impact factor: 4.310

9.  What does the measurement of whole-body fatty acid rate of appearance in plasma by using a fatty acid tracer really mean?

Authors:  Bettina Mittendorfer; Olivia Liem; Bruce W Patterson; John M Miles; Samuel Klein
Journal:  Diabetes       Date:  2003-07       Impact factor: 9.461

10.  Glucose-Mediated Glucose Disposal at Baseline Insulin Is Impaired in IFG.

Authors:  Mariam Alatrach; Christina Agyin; Rucha Mehta; John Adams; Ralph A DeFronzo; Muhammad Abdul-Ghani
Journal:  J Clin Endocrinol Metab       Date:  2019-01-01       Impact factor: 5.958

View more
  21 in total

Review 1.  Why does obesity cause diabetes?

Authors:  Samuel Klein; Amalia Gastaldelli; Hannele Yki-Järvinen; Philipp E Scherer
Journal:  Cell Metab       Date:  2022-01-04       Impact factor: 27.287

Review 2.  Cellular Senescence in Obesity and Associated Complications: a New Therapeutic Target.

Authors:  Akilavalli Narasimhan; Rafael R Flores; Christina D Camell; David A Bernlohr; Paul D Robbins; Laura J Niedernhofer
Journal:  Curr Diab Rep       Date:  2022-10-14       Impact factor: 5.430

Review 3.  Progression from prediabetes to type 2 diabetes mellitus induced by overnutrition.

Authors:  Yuli Zhang; Tuming Shen; Songtao Wang
Journal:  Hormones (Athens)       Date:  2022-10-05       Impact factor: 3.419

Review 4.  GLP-1 Agonist to Treat Obesity and Prevent Cardiovascular Disease: What Have We Achieved so Far?

Authors:  Maurício Reis Pedrosa; Denise Reis Franco; Hannah Waisberg Gieremek; Camila Maia Vidal; Fernanda Bronzeri; Alexia de Cassia Rocha; Luis Gabriel de Carvalho Cara; Sofia Lenzi Fogo; Freddy Goldberg Eliaschewitz
Journal:  Curr Atheroscler Rep       Date:  2022-08-31       Impact factor: 5.967

Review 5.  Obesity, Inflammation, and Immune System in Osteoarthritis.

Authors:  Udhaya Nedunchezhiyan; Ibin Varughese; Antonia RuJia Sun; Xiaoxin Wu; Ross Crawford; Indira Prasadam
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

Review 6.  Obesity and Pancreatic Cancer: Recent Progress in Epidemiology, Mechanisms and Bariatric Surgery.

Authors:  Shuhei Shinoda; Naohiko Nakamura; Brett Roach; David A Bernlohr; Sayeed Ikramuddin; Masato Yamamoto
Journal:  Biomedicines       Date:  2022-05-31

7.  Very-Long-Chain Unsaturated Sphingolipids Mediate Oleate-Induced Rat β-Cell Proliferation.

Authors:  Anne-Laure Castell; Alexis Vivoli; Trevor S Tippetts; Isabelle Robillard Frayne; Zuraya Elisa Angeles; Valentine S Moullé; Scott A Campbell; Matthieu Ruiz; Julien Ghislain; Christine Des Rosiers; William L Holland; Scott A Summers; Vincent Poitout
Journal:  Diabetes       Date:  2022-06-01       Impact factor: 9.337

8.  On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes: Reply to Johnson JD [letter].

Authors:  Nathalie Esser; Kristina M Utzschneider; Steven E Kahn
Journal:  Diabetologia       Date:  2021-07-29       Impact factor: 10.122

Review 9.  Hyperinsulinemia in Obesity, Inflammation, and Cancer.

Authors:  Anni M Y Zhang; Elizabeth A Wellberg; Janel L Kopp; James D Johnson
Journal:  Diabetes Metab J       Date:  2021-03-29       Impact factor: 5.893

10.  On the causal relationships between hyperinsulinaemia, insulin resistance, obesity and dysglycaemia in type 2 diabetes.

Authors:  James D Johnson
Journal:  Diabetologia       Date:  2021-07-22       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.